Voyageur Pharmaceuticals (CVE:VM) Stock Price Up 47.4% – What’s Next?

Voyageur Pharmaceuticals Ltd. (CVE:VMGet Free Report) rose 47.4% on Saturday . The company traded as high as C$0.14 and last traded at C$0.14. Approximately 1,312,210 shares changed hands during trading, an increase of 427% from the average daily volume of 249,010 shares. The stock had previously closed at C$0.10.

Voyageur Pharmaceuticals Stock Up 47.4 %

The business has a 50-day moving average of C$0.08 and a 200-day moving average of C$0.06. The company has a debt-to-equity ratio of 3.21, a quick ratio of 0.84 and a current ratio of 0.17. The stock has a market capitalization of C$19.53 million, a price-to-earnings ratio of -14.00 and a beta of 0.32.

About Voyageur Pharmaceuticals

(Get Free Report)

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.

Further Reading

Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.